ID   ZN304_HUMAN             Reviewed;         659 AA.
AC   Q9HCX3;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   28-JUN-2023, entry version 177.
DE   RecName: Full=Zinc finger protein 304 {ECO:0000312|HGNC:HGNC:13505};
DE   AltName: Full=KRAB-containing zinc finger protein {ECO:0000303|PubMed:12051768};
GN   Name=ZNF304 {ECO:0000312|HGNC:HGNC:13505};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLU-367, AND TISSUE SPECIFICITY.
RC   TISSUE=Thymus;
RX   PubMed=12051768; DOI=10.1016/s0006-291x(02)00344-3;
RA   Sabater L., Ashhab Y., Caro P., Kolkowski E.C., Pujol-Borrell R.,
RA   Dominguez O.;
RT   "Identification of a KRAB-containing zinc finger protein, ZNF304, by AU-
RT   motif-directed display method and initial characterization in lymphocyte
RT   activation.";
RL   Biochem. Biophys. Res. Commun. 293:1066-1072(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   FUNCTION, INTERACTION WITH USP28, POSSIBLE IDENTIFICATION IN A COREPRESSOR
RP   COMPLEX, CHROMATIN-BINDING, DEUBIQUITINATION BY USP28, TISSUE SPECIFICITY,
RP   AND INDUCTION.
RX   PubMed=24623306; DOI=10.7554/elife.02313;
RA   Serra R.W., Fang M., Park S.M., Hutchinson L., Green M.R.;
RT   "A KRAS-directed transcriptional silencing pathway that mediates the CpG
RT   island methylator phenotype.";
RL   Elife 3:E02313-E02313(2014).
RN   [4]
RP   FUNCTION, DNA-BINDING, AND TISSUE SPECIFICITY.
RX   PubMed=26081979; DOI=10.1038/ncomms8351;
RA   Aslan B., Monroig P., Hsu M.C., Pena G.A., Rodriguez-Aguayo C.,
RA   Gonzalez-Villasana V., Rupaimoole R., Nagaraja A.S., Mangala S., Han H.D.,
RA   Yuca E., Wu S.Y., Ivan C., Moss T.J., Ram P.T., Wang H., Gol-Chambers A.,
RA   Ozkayar O., Kanlikilicer P., Fuentes-Mattei E., Kahraman N., Pradeep S.,
RA   Ozpolat B., Tucker S., Hung M.C., Baggerly K., Bartholomeusz G., Calin G.,
RA   Sood A.K., Lopez-Berestein G.;
RT   "The ZNF304-integrin axis protects against anoikis in cancer.";
RL   Nat. Commun. 6:7351-7351(2015).
CC   -!- FUNCTION: Acts as transcriptional regulator and plays a role in gene
CC       silencing (PubMed:24623306, PubMed:26081979). Probably forms a
CC       corepressor complex required for activated KRAS-mediated promoter
CC       hypermethylation and transcriptional silencing of several tumor
CC       suppressor genes (TSGs) or other tumor-related genes in colorectal
CC       cancer (CRC) cells (PubMed:24623306). Also required to maintain a
CC       transcriptionally repressive state of genes in undifferentiated
CC       embryonic stem cells (ESCs) by inducing trimethylation of 'Lys-27' of
CC       histone H3 (H3K27me3) (PubMed:24623306) in a Polycomb group (PcG)
CC       complexes-dependent manner. Associates at promoter regions of TSGs and
CC       mediates the recruitment of the corepressor complex containing the
CC       scaffolding protein TRIM28, methyltransferase DNMT1 and histone
CC       methyltransferase SETDB1 and/or the PcG complexes at those sites
CC       (PubMed:24623306). Transcription factor involved in the metastatic
CC       cascade process by inducing cell migration and proliferation and gain
CC       resistance to anoikis of ovarian carcinoma (OC) cells via integrin-
CC       mediated signaling pathways (PubMed:26081979). Associates with the
CC       ITGB1 promoter and positively regulates beta-1 integrin transcription
CC       expression (PubMed:26081979). Promotes angiogenesis (PubMed:26081979).
CC       Promotes tumor growth (PubMed:24623306, PubMed:26081979).
CC       {ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:26081979}.
CC   -!- SUBUNIT: Probably part of a corepressor complex containing ZNF304,
CC       TRIM28, SETDB1 and DNMT1; leading to promoter hypermethylation and
CC       transcriptional silencing (PubMed:24623306). Probably associates with
CC       Polycomb group (PcG) complexes; leading to trimethylation of 'Lys-27'
CC       of histone H3 (H3K27me3) (PubMed:24623306). Interacts with USP28
CC       (PubMed:24623306). {ECO:0000269|PubMed:24623306}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:24623306}.
CC       Note=Associates with chromatin (PubMed:24623306).
CC       {ECO:0000269|PubMed:24623306}.
CC   -!- TISSUE SPECIFICITY: Expressed in undifferentiated embryonic stem cells
CC       (ESCs) (PubMed:24623306). Expressed strongly in colorectal cancers
CC       cells (CRCs) (PubMed:24623306). Expressed strongly in ovarian carcinoma
CC       (OC) tumor cell lines compared to non-transformed ovarian epithelial
CC       cells (at protein level) (PubMed:26081979). Expressed in lymphoid
CC       tissues, thyroid, adrenal gland, prostate, pancreas and skeletal
CC       muscles (PubMed:12051768). {ECO:0000269|PubMed:12051768,
CC       ECO:0000269|PubMed:24623306, ECO:0000269|PubMed:26081979}.
CC   -!- INDUCTION: Down-regulated during embryonic stem cells (ESCs)
CC       differentiation by retinoic acid treatment (PubMed:24623306).
CC       {ECO:0000269|PubMed:24623306}.
CC   -!- PTM: Deubiquitinated by USP28; the deubiquitination leads to the
CC       stabilization of ZNF304 from proteolytic degradation (PubMed:24623306).
CC       {ECO:0000269|PubMed:24623306}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ276316; CAC06610.1; -; mRNA.
DR   EMBL; AC005261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS12950.1; -.
DR   RefSeq; NP_065708.2; NM_020657.3.
DR   AlphaFoldDB; Q9HCX3; -.
DR   SMR; Q9HCX3; -.
DR   BioGRID; 121493; 5.
DR   CORUM; Q9HCX3; -.
DR   IntAct; Q9HCX3; 2.
DR   STRING; 9606.ENSP00000375586; -.
DR   GlyGen; Q9HCX3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9HCX3; -.
DR   PhosphoSitePlus; Q9HCX3; -.
DR   BioMuta; ZNF304; -.
DR   DMDM; 296453049; -.
DR   MassIVE; Q9HCX3; -.
DR   MaxQB; Q9HCX3; -.
DR   PaxDb; Q9HCX3; -.
DR   PeptideAtlas; Q9HCX3; -.
DR   ProteomicsDB; 81804; -.
DR   Antibodypedia; 46525; 21 antibodies from 12 providers.
DR   DNASU; 57343; -.
DR   Ensembl; ENST00000282286.6; ENSP00000282286.4; ENSG00000131845.15.
DR   Ensembl; ENST00000391705.7; ENSP00000375586.3; ENSG00000131845.15.
DR   GeneID; 57343; -.
DR   KEGG; hsa:57343; -.
DR   MANE-Select; ENST00000282286.6; ENSP00000282286.4; NM_020657.4; NP_065708.2.
DR   UCSC; uc010ygw.3; human.
DR   AGR; HGNC:13505; -.
DR   CTD; 57343; -.
DR   DisGeNET; 57343; -.
DR   GeneCards; ZNF304; -.
DR   HGNC; HGNC:13505; ZNF304.
DR   HPA; ENSG00000131845; Low tissue specificity.
DR   MIM; 613840; gene.
DR   neXtProt; NX_Q9HCX3; -.
DR   OpenTargets; ENSG00000131845; -.
DR   PharmGKB; PA37791; -.
DR   VEuPathDB; HostDB:ENSG00000131845; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000161016; -.
DR   HOGENOM; CLU_002678_44_5_1; -.
DR   InParanoid; Q9HCX3; -.
DR   OMA; KPHECNS; -.
DR   OrthoDB; 4709447at2759; -.
DR   PhylomeDB; Q9HCX3; -.
DR   TreeFam; TF339848; -.
DR   PathwayCommons; Q9HCX3; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   SignaLink; Q9HCX3; -.
DR   SIGNOR; Q9HCX3; -.
DR   BioGRID-ORCS; 57343; 11 hits in 1179 CRISPR screens.
DR   GenomeRNAi; 57343; -.
DR   Pharos; Q9HCX3; Tbio.
DR   PRO; PR:Q9HCX3; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9HCX3; protein.
DR   Bgee; ENSG00000131845; Expressed in secondary oocyte and 181 other tissues.
DR   ExpressionAtlas; Q9HCX3; baseline and differential.
DR   Genevisible; Q9HCX3; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0090309; P:positive regulation of DNA methylation-dependent heterochromatin formation; IMP:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 15.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24390; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24390:SF203; ZINC FINGER PROTEIN; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 11.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 16.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 10.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 16.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 15.
PE   1: Evidence at protein level;
KW   Activator; Angiogenesis; Chromatin regulator; DNA-binding; Metal-binding;
KW   Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..659
FT                   /note="Zinc finger protein 304"
FT                   /id="PRO_0000047523"
FT   DOMAIN          14..88
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         89..111
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         115..139
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         251..273
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         279..301
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         307..329
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         335..357
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         363..385
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         391..413
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         419..441
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         447..469
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         475..497
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         503..525
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         531..553
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         559..581
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         587..609
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         615..637
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   VARIANT         121
FT                   /note="L -> P (in dbSNP:rs862708)"
FT                   /id="VAR_019979"
FT   VARIANT         367
FT                   /note="K -> E (in dbSNP:rs862709)"
FT                   /evidence="ECO:0000269|PubMed:12051768"
FT                   /id="VAR_033563"
FT   CONFLICT        323
FT                   /note="V -> A (in Ref. 1; CAC06610)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="S -> P (in Ref. 1; CAC06610)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="R -> S (in Ref. 1; CAC06610)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   659 AA;  75047 MW;  11B5263F41DB2704 CRC64;
     MAAAVLMDRV QSCVTFEDVF VYFSREEWEL LEEAQRFLYR DVMLENFALV ATLGFWCEAE
     HEAPSEQSVS VEGVSQVRTA ESGLFQKAHP CEMCDPLLKD ILHLAEHQGS HLTQKLCTRG
     LCRRRFSFSA NFYQHQKQHN GENCFRGDDG GASFVKSCTV HMLGRSFTCR EEGMDLPDSS
     GLFQHQTTYN RVSPCRRTEC MESFPHSSSL RQHQGDYDGQ MLFSCGDEGK AFLDTFTLLD
     SQMTHAEVRP FRCLPCGNVF KEKSALINHR KIHSGEISHV CKECGKAFIH LHHLKMHQKF
     HTGKRHYTCS ECGKAFSRKD TLVQHQRVHT GERSYDCSEC GKAYSRSSHL VQHQRIHTGE
     RPYKCNKCGK AFSRKDTLVQ HQRFHTGERP YECSECGKFF SQSSHLIEHW RIHTGARPYE
     CIECGKFFSH NSSLIKHRRV HTGARSYVCS KCGKAFGCKD TLVQHQIIHT GARPYECSEC
     GKAFSRKDTL VQHQKIHTGE RPYECGECGK FFSHSSNLIV HQRIHTGAKP YECNECGKCF
     SHNSSLILHQ RVHTGARPYV CSECGKAYIS SSHLVQHKKV HTGARPYECS ECGKFFSRNS
     GLILHQRVHT GEKPYVCSEC GKAYSRSSHL VRHQKAHTGE RAHECNSFGG PLAASLKLV
//
